Ghazy, Ehab published the artcileSynthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis, Recommanded Product: 3-(Methoxycarbonyl)benzoic acid, the publication is European Journal of Medicinal Chemistry (2021), 113745, database is CAplus and MEDLINE.
In this study, the previously reported benzhydroxamate-based inhibitors I, II [X = H, chloro, methoxy, etc;R = 4-biphenyl, 3-benzyloxyphenyl, 4-propoxyphenyl, etc.] of Schistosoma mansoni histone deacetylase 8 (smHDAC8) were chem. optimized. Crystallog. anal. provided insights into the inhibition mode of smHDAC8 activity by the highly potent inhibitor I[X = methoxy;R = 4-Dibenzofuranyl]. Structure-based optimization of the novel inhibitors was carried out using the available crystal structures as well as docking studies on smHDAC8. The compounds were evaluated in screens for inhibitory activity against schistosome and human HDACs (hHDAC). The in vitro and docking results were used for detailed structure activity relationships. The synthesized compounds were further investigated for their lethality against the schistosome larval stage using a fluorescence-based assay. The most promising inhibitor I[X = methoxy;R = 4-Dibenzofuranyl] showed significant dose-dependent killing of the schistosome larvae and markedly impaired egg laying of adult worm pairs maintained in culture.
European Journal of Medicinal Chemistry published new progress about 1877-71-0. 1877-71-0 belongs to esters-buliding-blocks, auxiliary class Carboxylic acid,Benzene,Ester, name is 3-(Methoxycarbonyl)benzoic acid, and the molecular formula is C9H8O4, Recommanded Product: 3-(Methoxycarbonyl)benzoic acid.
Referemce:
https://en.wikipedia.org/wiki/Ester,
Ester – an overview | ScienceDirect Topics